Acceptability and feasibility of tests for infection, serological testing and photography to define need for interventions against trachoma
Preprint
Abstract
Background: Trachoma causes blindness due to repeated conjunctival infection by Chlamydia trachomatis ( Ct ). Transmission intensity is estimated, for programmatic decision-making, by prevalence of the clinical sign trachomatous inflammation—follicular (TF) in children aged 1–9 years. Research into complementary indicators to field-graded TF includes work on conjunctival photography, tests for ocular Ct infection, and serology. The perceived acceptability and feasibility of these indicators among a variety of stakeholders is unknown. Methodology: Focus group discussions (FGDs) with community members and in-depth interviews (IDIs) with public health practitioners in Tanzania were conducted. FGDs explored themes including participants’ experience with, and thoughts about, different diagnostic approaches. The framework method for content analysis was used. IDIs yielded lists of perceived strengths of, and barriers to, implementation for programmatic use of each indicator. These were used to form an online quantitative survey on complementary indicators distributed to global stakeholders via meetings, mailing lists, and social media posts. Results: Sixteen FGDs and 11 IDIs were conducted in October–November 2022. In general, all proposed sample methods were deemed acceptable by community members. Common themes included not wanting undue discomfort and a preference for tests perceived as accurate. Health workers noted the importance of community education for some sample types. The online survey was conducted in April–May 2023 with 98 starting the questionnaire and 81 completing it. Regarding barriers to implementing diagnostics, the highest agreement items related to feasibility, rather than acceptability. No evidence of significant differences was found in responses pertaining to community acceptability based on participant characteristics. Conclusions: All of the indicators included were generally deemed acceptable by all stakeholders in Tanzania, although community education around the benefits and risks of different sample types, as well as addressing issues around feasibility, will be key to successful, sustainable integration of these indicators into trachoma programs. Author Summary: Trachoma is a disease that causes blindness through conjunctival infection with the bacterium Chlamydia trachomatis . Trachoma is targeted for global elimination by 2030. To know whether population-level interventions are required, we must know how intensely conjunctival C. trachomatis is being transmitted in a population. The current proxy recommended by the World Health Organization is prevalence of a clinical sign of active (inflammatory) trachoma: trachomatous inflammation—follicular. However, this indicator has several drawbacks. Policy-makers are considering the utility of a number of complementary indicators, including conjunctival photography and tests for infection and serology. We sought the opinions of different stakeholders to determine the acceptability and feasibility of complementary indicators for use in trachoma programs. In Tanzania, we undertook focus group discussions with community members and in-depth interviews with public health practitioners. We also conducted an online survey of global stakeholders. We found that all the proposed test types were acceptable to stakeholders in Tanzania; common themes included not wanting undue discomfort and a preference for test types perceived to be accurate. Community education and building trust was deemed critical. From the online survey, the most agreed-upon barriers to implementation of each method were related to concerns about feasibility, rather than acceptability.Keywords
All Related Versions
- Published version: PLOS Neglected Tropical Diseases, 18 (6), e0011941.
This publication has 28 references indexed in Scilit:
- Accuracy, acceptability and feasibility of photography for use in trachoma surveys: a mixed methods study in TanzaniaInternational Health, 2023
- Tropical Data: Approach and Methodology as Applied to Trachoma Prevalence SurveysOphthalmic Epidemiology, 2023
- Vaccination against COVID-19: A systematic review and meta-analysis of acceptability and its predictorsPreventive Medicine, 2021
- Acceptability and perceived utility of different diagnostic tests and sample types for trachoma surveillance in the Bijagos Islands, Guinea BissauTransactions of the Royal Society of Tropical Medicine and Hygiene, 2021
- Caregiver willingness to vaccinate their children against COVID-19: Cross sectional surveyVaccine, 2020
- Understanding hard-to-reach communities: local perspectives and experiences of trachoma control among the pastoralist Maasai in northern TanzaniaJournal of Biosocial Science, 2020
- Two Doses of Azithromycin to Eliminate Trachoma in a Tanzanian CommunityNew England Journal of Medicine, 2008
- Acceptability of azithromycin for the control of trachoma in Northern TanzaniaTransactions of the Royal Society of Tropical Medicine and Hygiene, 2005
- Clinical examination and laboratory tests for estimation of trachoma prevalence in a remote setting: what are they really telling us?The Lancet Infectious Diseases, 2005
- Household decisions among the Gogo people of Tanzania: Determining the roles of men, women and the community in implementing a trachoma prevention programSocial Science & Medicine, 1992